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Objectives This study evaluated whether coronary artery calcium scores (CACS) and the degree of stenosis that were mea-
sured with computed tomography coronary angiography (CTCA) predicted post-operative cardiovascular events in
patients who were undergoing intermediate-risk noncardiac surgery.
Background Cardiovascular complications are important causes of mortality and morbidity in patients undergoing major non-
cardiac surgeries.
Methods A total of 239 patients underwent CTCA before intermediate-risk noncardiac surgeries. We measured CACS and
the degree of stenosis with CTCA and assessed clinical risk factors according to the revised cardiac risk index
(RCRI) scores. Post-operative cardiovascular events were defined as cardiac death, acute coronary syndrome,
pulmonary edema, ventricular arrhythmia with hemodynamic compromise, and complete heart block.
Results Nineteen patients (8%) had post-operative cardiac events. The variables that correlated with the occurrence of
cardiac events were RCRI (p  0.001), CACS (p  0.001), the presence of significant coronary artery stenosis
(diameter stenosis 50%) (p  0.01), and multivessel coronary artery disease (p  0.001). In the receiver-
operating characteristic (ROC) curve analysis of CACS for prediction of cardiac events, the cutoff value was 113
(sensitivity, 0.79; specificity, 0.61; area under the curve, 0.762). When comparing ROC curves of the combina-
tion models of RCRI, high CACS (113), and the presence of multivessel disease, RCRI plus high CACS, RCRI
plus multivessel disease, and RCRI plus high CACS plus multivessel disease were significantly more predictable
of post-operative cardiovascular events than RCRI alone.
Conclusions In the pre-operative risk stratification of patients who were undergoing intermediate-risk noncardiac surgeries,
CTCA evaluations showed additive value to RCRI. (J Am Coll Cardiol 2013;61:661–8) © 2013 by the
American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.09.060Post-operative cardiovascular events, such as cardiac death,
acute coronary syndrome, pulmonary edema, and severe ven-
tricular arrhythmia, are the most significant risks to patients
undergoing noncardiac surgery (1,2). The identification of
high-risk patients is needed for preventive management and
prompt treatment during the perioperative period.
According to the American College of Cardiology/
American Heart Association (ACC/AHA) guidelines (3),
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2012, accepted September 16, 2012.noninvasive cardiac risk evaluations are only recommended
for patients with a poor or unknown functional capacity who
have 1 or more clinical risk factors and are undergoing
vascular or intermediate-risk surgery. A treadmill test, stress
myocardial perfusion scintigraphy, or stress echocardiogra-
phy are recommended as noninvasive cardiac tests for the
detection of obstructive coronary artery disease.
See page 669
Computed tomography coronary angiography (CTCA)
is a reliable and noninvasive method that is used for the
assessment of coronary artery disease, coronary anatomy,
and cardiac function (4,5). A high negative predictive
value (NPV) and a high specificity for stenoses allow for
effectively ruling out coronary artery disease in patients with
d662 Ahn et al. JACC Vol. 61, No. 6, 2013
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diagnostic or equivocal noninva-
sive cardiac stress tests. However,
the Appropriate Use Criteria for
Cardiac Computed Tomography
(AUCCCT), which was pub-
lished in 2010, recommends that
there are no appropriate indica-
tions for CT as part of pre-
operative evaluations for noncar-
diac surgery (6), which is due to
the lack of studies showing direct
benefits of its use in the perioper-
ative period.
Therefore, we evaluated whether
coronary artery calcium scores
(CACS) and the degree of stenosis
that were measured with CTCA
predicted post-operative cardio-
vascular events in patients who
were undergoing intermediate-risk
noncardiac surgeries.
Methods
Study populations. From Janu-
ary 2007 to December 2009, 878
consecutive patients were exam-
ined with CTCA before surgery.
We included only patients who
were undergoing intermediate-
risk noncardiac surgeries for in-
trathoracic, intraperitoneal, or-
thopedic, head and neck, and prostate disease (3). We
excluded patients who were undergoing high- and low-risk
operations (n 618). In addition, we excluded patients who
had recent (within 1 month) myocardial infarctions (n 3),
acute decompensated heart failure (n  2), severe valvular
isease (n  5), or fatal cardiac arrhythmias (n  2).
Patients with immeasurable CACS due to poor image
quality because of motion artifacts (n  6) and those who
were undergoing preventive coronary interventions after the
CTCA evaluations (n  3) were also excluded. Finally, in
this study, a total of 239 CACS and 234 coronary artery
stenosis evaluations were analyzed. We could not evaluate
the coronary artery stenosis of 5 patients due to heavy
calcification and motion artifacts (Fig. 1). This study was
approved by the local institutional review board with waiver
of individual consent.
CTCA analysis. CTCA was performed with a 64-slice
system (Brilliance 64, Philips Healthcare, Best, the Neth-
erlands). Patients with a heart rate 80 beats/min received
oral propranolol given in 40-mg increments (up to 120 mg)
before the CTCA scan. A low-osmolar nonionic contrast
agent (90 to 100 cc Ultravist 370, Berlex, Wayne, New
Abbreviations
and Acronyms
ACC/AHA  American
College of Cardiology/
American Heart Association
AUC  area under the
curve
AUCCCT  Appropriate Use
Criteria for Cardiac
Computed Tomography
CACS  coronary artery
calcium scores
CHF  congestive heart
failure
CI  confidence interval
CTCA  computed
tomography coronary
angiography
ECG  electrocardiography
IDI  integrated
discrimination improvement
NPV  negative predictive
value
NRI  net reclassification
improvement
OR  odds ratio
PPV  positive predictive
value
RCRI  revised cardiac risk
index
ROC  receiver-operating
characteristicJersey) was injected into the antecubital vein at flow ratesbetween 3.5 and 4.5 ml/s. After the contrast injection, a
retrospective electrocardiographic (ECG)-gated spiral scan
was performed that covered the region immediately beneath
the aortic arch to the apex of the left ventricle during an
inspiratory breath hold of 10 to 20 ms, depending on the
particular scanner. The scan parameters were gantry rota-
tion, 330 to 420 ms, and spiral imaging with retrospective
ECG gating and dose modulation (ECG pulsing), 750 to
850 mA, 120 kV, and 0.75-mm slice thickness. For all
scanners, a multisegment algorithm was used to reconstruct
overlapping images that were typically at 75% of the cardiac
cycle. CACS was measured without contrast with semiau-
tomated software (HeartBeat CS, Philips Medical Systems)
that displayed colored spots representing calcium, which
were manually marked by the operator and automatically
used to calculate a summed CACS.
We classified the grades of maximal stenosis as normal or
minimal stenosis (luminal diameter narrowing 30%), nonsig-
nificant stenosis (30%  luminal diameter narrowing 50%),
or significant stenosis (50% luminal diameter narrowing).
Angiographically significant disease was classified as no
significant stenosis, single-vessel disease if there was signif-
icant stenosis in 1 vessel; 2-vessel disease if there was
significant stenosis in 2 vessels, and 3-vessel disease if there
was significant stenosis in 3 vessels.
Pre-operative risk assessments. We reviewed the medical
records for clinical risk factors and laboratory findings for all
patients. Body mass index (kilograms divided by meters
squared), hemoglobin (grams per deciliter), glycosylated
hemoglobin A1c (HbA1c; percentage), and the glomerular
Figure 1 Profile of Patient Enrollment
CTCA  computed tomography coronary angiography; CACS  coronary artery
calcium scores; HF  heart failure; MI  myocardial infarction; PCI  percuta-
neous coronary intervention.
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February 12, 2013:661–8 CT Coronary Angiography Before Noncardiac Surgeryfiltration rate (milliliter per minute) were obtained at the
time of the CTCA. The revised cardiac risk index (RCRI)
was calculated for each patient. The RCRI relies on the
presence or absence of the following 6 identifiable predictive
factors: high-risk surgery (intrathoracic, intraperitoneal, or
suprainguinal vascular surgery), ischemic heart disease, con-
gestive heart failure (CHF), cerebrovascular disease, insulin
therapy with diabetes mellitus, and renal dysfunction (serum
creatinine level 2.0 mg/dl). Each of these predictors was
assigned 1 point. According to the ACC/AHA guidelines
(3), intrathoracic or intraperitoneal surgeries are classified as
intermediate surgical procedures, whereas the RCRI desig-
nates these surgeries as high-risk procedures. Therefore,
intrathoracic and intraperitoneal surgeries were assigned 1
point when the RCRI was calculated.
Definition of post-operative adverse events. The post-
operative cardiovascular events were defined as cardiac death,
acute coronary syndrome (nonfatal myocardial infarction and
unstable angina), pulmonary edema, ventricular fibrillation,
ventricular tachycardia with hemodynamic compromise, and
complete heart block within 30 days after surgery (7).
Cardiac death was defined as sudden death or death
secondary to myocardial infarction, arrhythmia, or heart
failure. Myocardial infarction was defined as troponin I
levels that increased to 2 times the upper limit of normal,
which were associated with at least 1 of the following: new
Q waves on ECG (30 ms in 2 continuous leads), persis-
tent significant ST elevation or depression on the ECG, or
a new regional wall motion abnormality with ECG (8).
Unstable angina was defined as the appearance of reversible
ischemic ST changes that accompanied clinical symptoms
without increased levels of troponin I.
Statistical analysis. Statistical analysis was performed with
PSS for Windows, version 12.00 (IBM Corporation,
rmonk, New York) and SAS for Window, version 9.1
SAS Institute Inc., Cary, North Carolina). Continuous
ariables were expressed as medians and quartiles, and
ategorical data were expressed as numbers and percentages.
he Mann-Whitney U test was used to compare continuous
ariables. The chi-square test or Fisher exact test was used
o compare categorical variables between groups. Binary
ogistic regression analysis by the enter method was used to
etermine the independent predictors of post-operative
ardiovascular events. The odds ratio (OR) and its 95%
onfidence interval (CI) were calculated. All p values refer to
-tailed tests of significance. A receiver-operating character-
istic (ROC) curve analysis of CACS was performed to identify
the optimal cutoff value for the prediction of post-operative
cardiovascular events. The optimal cutoff point of CACS was
calculated by the Euclidean method. The sensitivity, specific-
ity, positive predictive value (PPV), and NPV of the prediction
of cardiovascular events were calculated. Finally, we compared
2 or more ROC curves using the area under the curve (AUC)
comparison analysis method as described by DeLong et al. (9).
e also calculated the integrated discrimination improvement
IDI) and the net reclassification improvement (NRI) with aategory-free option among models following the methodol-
gy of Pencina et al. (10,11). Values of p  0.05 were
onsidered significant.
esults
atient characteristics. Post-operative cardiovascular events
ccurred in 19 patients (8%; 11 men; age 70 10 years). There
ere 8 cases of cardiac death, 2 cases of nonfatal myocardial
nfarction, 2 cases of unstable angina, 5 cases of pulmonary
dema with heart failure, 1 case of ventricular tachycardia with
emodynamic compromise, and 1 case of complete atrioven-
ricular block. Three patients died because of noncardiac
auses; 1 patient had wound leakage and bleeding on the
econd post-operative day, and 2 patients had pneumonia on
he eighth and twenty-first days after their surgeries.
The prevalences of hypertension, chronic kidney disease,
ngina, and the history of heart failure were higher in
atients with post-operative cardiovascular events. Serum
lbumin levels, hemoglobin levels, and estimated glomerular
ltration rates were significantly lower in patients with events.
he use of calcium channel blockers was significantly higher in
atients with events. The use of concomitant medications,
uch as insulin, beta-blockers, or 3-hydroxy-3-methylglutaryl
oenzyme A reductase inhibitors, was not related to post-
perative cardiac events (Table 1).
CRI and events. Patients were grouped into 4 RCRI
lasses according to 0, 1, 2, or3 clinical predictors (Table 2).
CRI scores identified 105 patients (43.9%) with a score of 0
no clinical predictors), 98 (41.0%) with a score of 1 (1 clinical
redictor), 28 (11.7%) with a score of 2 (2 clinical predictors),
nd 8 (3.3%) with a score of 3 (3 or more clinical predictors).
hese patients had event rates of 5.7%, 4.1%, 14.3%, and
2.5%, respectively. In patients with RCRI scores of 0 as a
eference, the OR for experiencing a post-operative event for
atients with scores of 1, 2, or 3 were 0.51 (95% CI: 0.20 to
.61, p  0.611), 2.91 (95% CI: 0.79 to 9.47, p  0.178), or
10.94 (95% CI: 2.73 to 43.81, p 0.001), respectively (Table 2).
As shown, the post-operative events rate tended to increase
in patients with higher RCRI scores. However, only the
group with RCRI scores of 3 had statistically significant
differences.
Coronary artery stenosis and CACS in CTCA. Patients
with significant coronary artery stenosis had more post-
operative events compared with those with minimal stenosis
and nonsignificant stenosis. With the OR of those with
minimal stenosis used as a reference group, the ORs were
2.11 (95% CI: 0.39 to 11.45, p  0.388) for nonsignificant
stenosis and 5.69 (95% CI: 1.89 to 17.15, p  0.002) for
significant stenosis.
Angiographically significant disease was categorized into
4 groups ranging from no significant stenosis to 3-vessel
disease. Patients with multivessel coronary artery disease (2-
and 3-vessel disease) had significantly more events com-
pared with those with no significant stenosis or single-vessel
coronary artery disease. With the OR of those with no
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CT Coronary Angiography Before Noncardiac Surgery February 12, 2013:661–8significant stenosis used as a reference group, the ORs were
11.64 (95% CI: 3.38 to 40.15, p  0.001) for 2-vessel
disease and 8.32 (95% CI: 2.33 to 29.64, p  0.001) for
3-vessel disease (Table 3).
The median CACS for the total group of 239 patients
was 52.68 (interquartile range: 0.00 to 262.74). The value of
CACS in patients with events (median, 359.27; interquar-
tile range: 179.29 to 1,421.47) was significantly higher than
in those without events (median, 0.00; interquartile range:
0.00 to 29.12, p  0.001). In the ROC curve analysis of
ACS predicting post-operative cardiac events, the AUC
as 0.762 (95% CI: 0.674 to 0.849, p  0.001) and the
ptimal CACS cutoff value was 113 (sensitivity, 79%;
pecificity, 61%; PPV, 15%; NPV, 97%). The OR of those
Baseline CharacteristicsTable 1 Baseline Characteristics
Characteristics Total (n  239)
Male 125 (52.3%)
Age (yrs) 69 (62–75)
Height (cm) 161.6 (153.0–168.0)
Weight (kg) 61.6 (53.7–70.0)
Body mass index (kg/m2) 23.5 (21.4–26.4)
GFR (ml/min) 78.3 (60.8–100.0)
Albumin (g/dl) 3.8 (3.4–4.1)
Hemoglobin (g/dl) 12.1 (10.8–13.5)
HbA1c (%) 6.4 (5.6–7.2)
Current smoking habits 88 (36.8%)
Diabetes 94 (39.3%)
Hypertension 172 (72.0%)
Cerebrovascular accident 26 (10.9%)
Chronic kidney disease 21 (8.8%)
Previous myocardial infarction 11 (4.6%)
Angina pectoris 41 (17.2%)
Heart failure 8 (3.3%)
ECG abnormalities 118 (49.4%)
ACE inhibitors or ARB 99 (41.4%)
Calcium channel blockers 97 (40.7%)
Beta-blockers 58 (24.3%)
Digoxin 14 (5.9%)
Antiplatelet agents 101 (42.3%)
Warfarin 8 (3.3%)
Thiazolidinediones 3 (1.3%)
HMG-CoA reductase inhibitors 54 (22.6%)
Insulin 31 (13.0%)
Values are n (%) or medians (25th to 75th percentiles). *Significant p
ACE  angiotensin-converting enzyme; ARB  angiotensin recep
HbA1c  glycosylated hemoglobin A1c; HMG-CoA  3-hydroxy-3-meth
Revised Cardiac Risk IndexTable 2 Revised Cardiac Risk Index
Risk
Factors
No. of Events/No. of Total
Patients (Event Rate %)
Odds Ratio
(95% CI) p Value
None 6/105 (5.7%) Reference group
1 4/98 (4.1%) 0.51 (0.20–2.61) 0.611
2 4/28 (14.3%) 2.91 (0.79–9.47) 0.178
3 or more 5/8 (62.5%) 10.94 (2.73–43.81) 0.001i
Values are n/N (%).
CI  confidence interval.ith high CACS ( 113) was 5.84 (95% CI: 1.88 to 18.19,
 0.001) for cardiovascular events (Table 3).
To examine whether CACS and multivessel disease were
ndependent predictors of post-operative cardiovascular
vents, a multivariate analysis was performed using CTCA
actors and the significant risk factors of the RCRI obtained
n univariate analysis (Table 4). In Model 1, which included
igh CACS (113) and the 3 clinical predictors, high
ACS, CHF, and ischemic heart disease were independent
ignificant predictors. In Model 2, which included the
resence of multivessel disease, CHF and multivessel dis-
ase were independent predictors. In the final model (Model
), which included all 3 clinical predictors and 2 CTCA
arameters, only the presence of multivessel disease and CHF
emained as independent predictors of cardiovascular events.
redictive value of the RCRI score and CTCA parameters.
ach RCRI score group was re-stratified based on high or
ow CACS (using a cutoff point of 113 on CACS) and the
resence or absence of multivessel disease (Fig. 2). In the
ame RCRI score group, the post-operative events rate was
igher in patients with CACS 113 than in those with
ACS 113; specifically, the rates were 15.2% versus 1.4%
or those with CACS 113 versus those with CACS 113
events (n  220) Events (n  19) p Value
14 (51.8%) 11 (57.9%) 0.611
69 (62–75) 72 (64–78) 0.261
1.5 (153.0–168.0) 162.0 (150.6–167.0) 0.917
2.0 (54.0–72.2) 60.0 (52.0–65.0) 0.297
3.7 (21.4–26.5) 22.4 (20.8–25.4) 0.182
0.3 (61.2–100.1) 65.2 (41.0–75.8) 0.014*
3.8 (3.4–4.2) 3.2 (2.6–3.7) 0.001*
2.2 (11.0–13.6) 10.7 (10.2–11.7) 0.001*
6.4 (5.6–7.2) 6.3 (5.8–6.9) 0.940
81 (36.8%) 7 (36.8%) 1.000
83 (37.7%) 11 (57.9%) 0.084
54 (70.0%) 18 (94.7%) 0.021*
23 (10.5%) 3 (15.8%) 0.474
16 (7.3%) 5 (26.3%) 0.005*
9 (4.1%) 2 (10.5%) 0.199
33 (15.0%) 8 (42.1%) 0.003*
3 (1.4%) 5 (26.3%) 0.001*
05 (47.7%) 13 (68.4%) 0.083
90 (40.9%) 9 (47.4%) 0.583
85 (38.6%) 12 (63.2%) 0.037*
52 (23.6%) 6 (31.6%) 0.438
12 (5.5%) 2 (10.5%) 0.366
89 (40.5%) 12 (63.2%) 0.055
7 (3.2%) 1 (5.3%) 0.628
2 (0.9%) 1 (5.3%) 0.102
47 (21.4%) 7 (36.8%) 0.122
29 (13.2%) 2 (10.5%) 0.741
(p  0.05).
cker; ECG, electrocardiography; GFR  glomerular filtration rate;
yl coenzyme A.No
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in the RCRI score 2 group, and 66.7% versus 50.0%,
respectively, in the RCRI score 3 or more group (Fig. 2A).
Similarly, there were more post-operative events in patients
with multivessel disease than in those without multivessel
disease in each RCRI group (Fig. 2B).
We conducted each ROC curve analysis of the predictive
models using RCRI scores, RCRI plus CACS scores (with
CACS 113 defined as a single independent predictive
factor), RCRI plus multivessel disease (with 2- or 3-vessel
disease defined as a single independent predictive factor),
and RCRI plus CACS scores plus multivessel disease (Fig. 3).
Based on the results of differences among the AUCs, RCRI
plus CACS 113 score, RCRI plus multivessel disease, and
RCRI plus CACS 113 plus multivessel disease were signif-
cantly more predictive of post-operative cardiovascular events
han RCRI alone. Additionally, to estimate the incremental
alue of CTCA to predict cardiovascular events, we compared
he probabilities of events and nonevents of models using the
elative IDI and category-free NRI. The IDI of adding
ultivessel disease to the RCRI improved significantly (rela-
ive IDI for CACS 113  0.39, p  0.098; for multivessel
disease 1.67, p 0.001; and for the combined CACS113
and multivessel disease  1.78, p  0.001) (Table 5). The
addition of CACS 113 and/or multivessel disease to the
RCRI resulted in a significant improvement of the category-
free NRI (Table 5). The model that included 2 CTCA
parameters (RCRI plus CACS113 plus multivessel disease)
Multivariate Analysis of Post-Operative Cardiovascular EventsTable 4 Multivariate Analysis of Post-Operative Cardiovascular
Characteristics
Model 1
OR (95% CI) p Value
Ischemic heart disease 3.10 (1.06–9.04) 0.039*
Congestive heart failure 10.11 (1.94–52.72) 0.006*
Renal dysfunction† 2.59 (0.66–10.21) 0.174
CACS 113 4.21 (1.25–14.18) 0.020*
Multivessel disease — —
Correlations of Computed Tomographic FindingsP st-Operative ardiovascular EventsTable 3 Correlations of Computed TomograpPost-Operative Cardiovascular Even
Characteristics
No. of Even
Patients (
Maximum stenosis
Normal 5/14
Nonsignificant CAD 2/2
Significant CAD 11/6
Angiographically significant disease
No significant stenosis 7/17
Single-vessel disease 0/2
2-vessel disease 6/1
3-vessel disease 5/1
Coronary artery calcium score  113 15/10
Values are n/N (%).
CAD  coronary artery disease; CI  confidence interval.*Significant p values (p  0.05). †Serum creatinine level  2.0 mg/dl.
CACS  coronary artery calcium score; CI  confidence interval; OR  odds ratio.showed the largest AUC (0.769  0.062) and highest relative
IDI and NRI for the prediction of cardiovascular events.
Discussion
In this study, a higher RCRI, a high CACS (113), the
presence of significant coronary artery stenosis (diameter
stenosis 50%), and multivessel coronary artery disease
were significantly associated with post-operative cardiovas-
cular events. However, the RCRI alone was not sufficiently
sensitive for estimating risk in patients with 2 or fewer risk
predictors, because the RCRI was only significant in pa-
tients with scores of 3 or more. For each group with a
different RCRI, the CTCA results stratified the post-
operative risk of patients more accurately. Compared with
the predictive models using the ROC curve analysis, IDI,
and NRI, the combination model that added CACS 113
nd/or multivessel disease to RCRI was more predictive
han the single predictive model of RCRI only for post-
perative cardiovascular events. Among combination mod-
ls, the use of a 2 CTCA parameters combination was
uperior to a single CTCA parameter in risk prediction.
Accumulating bodies of evidence have shown that
TCA is a reliable, noninvasive method for visualization of
ative coronary arteries. CTCA enables direct assessment of
he degree and number of significant coronary stenoses and
he presence of vulnerable plaques. CTCA can be a useful
ool for stress-intolerant patients or subjects who show low
ts
Model 2 Model 3
R (95% CI) p Value OR (95% CI) p Value
(0.55–6.00) 0.330 1.87 (0.57–6.12) 0.302
(1.27–72.43) 0.028* 7.78 (1.16–51.90) 0.034*
(0.33–7.57) 0.574 1.81 (0.38–8.58) 0.457
— — 2.66 (0.69–10.22) 0.155
(2.25–23.69) 0.001* 4.75 (1.33–16.90) 0.016*
indings With
. of Total
Rate %) Odds Ratio (95% CI) p Value
%) Reference group
%) 2.11 (0.39–11.45) 0.388
2%) 5.69 (1.89–17.15) 0.002
%) Reference group
— 0.998
3%) 11.64 (3.38–40.15) 0.001
3%) 8.32 (2.33–29.64) 0.001
1%) 5.84 (1.88–18.19) 0.001Even
O
1.81
9.61
1.57
7.31Withhic F
ts
ts/No
Event
2 (3.5
8 (7.1
4 (17.
0 (4.1
7 (0%)
8 (33.
9 (26.
1 (14.
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bundle branch block on ECG [12]), or before undergoing
severe cardiac valve surgery (13–15), or in those with dilated
cardiomyopathy (16). However, for pre-operative cardiac
evaluations, only a few reports have demonstrated the
usefulness of CTCA in selective patients undergoing valve
surgeries (13–15), liver transplantations (17), and noncoro-
nary cardiac surgeries (18). To our knowledge, this is the
first study to demonstrate that CTCA was a useful tool for
predicting post-operative cardiovascular events in patients
undergoing intermediate-risk noncardiac surgeries.
According to the ACC/AHA guidelines (3), noninvasive
cardiac risk evaluations are only recommended for patients
with poor or unknown functional capacities who have 1 or
more clinical risk factors and are undergoing vascular or
intermediate-risk surgery (19). Exercise ECG testing, stress
myocardial perfusion scintigraphy, and dobutamine stress
echocardiography are widely used. However, a considerable
Figure 2 Reclassification of the Revised Cardiac Risk Index Us
Reclassification using coronary artery calcium scores (CACS) of 113 or more (A) anumber of pre-operative patients cannot tolerate optimal ex-ercise protocols, and abnormalities on resting ECG result in an
inability to interpret ischemic changes. Pharmacologically-
induced cardiac stress testing is also contraindicated because
of safety considerations. In this regard, novel modalities are
needed to evaluate perioperative cardiovascular risks and
screen high-risk patients more safely and reliably. In this
study, the PPV and NPV of CACS 113 for cardiac death
and myocardial infarction were 9% and 98%, respectively,
and the PPV and NPV of multivessel disease were 19% and
98%, respectively. These results were comparable to values
of other noninvasive tests shown in the ACC/AHA guide-
lines (3): PPV of 2% to 20% and NPV of 97% to 100% in
stress myocardial perfusion scintigraphy, and PPV of 0% to
33% and NPV of 93% to 100% in dobutamine stress
echocardiography.
The ACC/AHA guidelines (3) recommend invasive cor-
onary angiography and revascularization for patients with
acute cardiac conditions and high-risk ischemia with non-
oronary Artery Calcium Scores
presence or absence of multivessel disease (B).ing C
nd theinvasive modalities. However, invasive modalities, including
667JACC Vol. 61, No. 6, 2013 Ahn et al.
February 12, 2013:661–8 CT Coronary Angiography Before Noncardiac Surgeryrevascularization, have higher procedure-related risks than
CTCA. CTCA provides precise information with respect to
the site and degree of coronary artery stenosis in high-risk
patients. Therefore, it might preclude the unnecessary
duplication of noninvasive and invasive studies for appro-
priate revascularization.
Contrast media and radiation exposure are prerequisites
for CTCA. The use of contrast media may cause allergic
reactions or extravasations and is contraindicated in patients
with poor renal function (20). Because CACS does not use
contrast, it might be a good option for patients with a
history of contrast media allergies or renal dysfunction. One
of the concerns of CTCA is radiation exposure. However,
radiation doses in CTCA are usually similar to those used in
myocardial perfusion scintigraphy (20). Recent advancements
Figure 3 Receiver-Operating Curve Comparison
Comparison of the receiver-operating characteristic (ROC) curves of the revised
cardiac risk index (RCRI) and/or the coronary artery calcium score (CACS) and
the presence of multivessel disease.
Comparisons of AUCs, IDI, and NRI for CTCA ParametersTable 5 Comparisons of AUCs, IDI, and NRI for CTCA Paramete
Models AUC SE 95% CI
p V
(Diff
Betwe
RCRI 0.652 0.079 0.587–0.713 Refere
RCRI  CACS 113 0.731 0.063 0.669–0.786 0.0
RCRI  Multivessel disease 0.719 0.074 0.656–0.775 0.0
0.7
RCRI  CACS 113  multivessel
disease
0.770 0.062 0.711–0.822 0.0
0.0
0.0
*Comparison with the ROC curves of RCRI (reference group). †Comparison with the ROC curves of
p values.AUC  area under the curve; CACS  coronary artery calcium score; CI  confidential interval; IDI  i
cardiac risk index; ROC  receiver-operating characteristics.in techniques, such as small scan volume, low tube current, and
prospective ECG gating, can minimize radiation exposure. In
clinical practice, the additional cost associated with CTCA is
another concern. A few studies reported that CTCA for
coronary artery disease is less costly overall and more effective
in patients with chest pain (21,22). A cost-effectiveness analysis
of the CTCA for post-operative risk stratification has not been
reported. We believe that the CTCA is a valuable, cost-
effective tool because intermediate-risk operations are associ-
ated with a considerable rate of death and myocardial infarc-
tion (1% to 5%); however, further studies regarding cost
effectiveness are needed.
Study limitations. First, the principal methodological lim-
itation was the retrospective use of medical records, leading
to the possibility of selection bias, because we excluded
patients who underwent prophylactic coronary revascular-
ization for left main or left main–equivalent coronary artery
disease; this may have resulted in an underestimation of
cardiovascular events. Second, because image reconstruction
artifacts that are related to radiodense materials, such as
calcium or metal, can obscure the coronary artery lumen, this
artifact may have led to both an under- and an overestimation
of coronary stenosis and calcium scores. Third, routine collec-
tion of post-operative serial ECG and cardiac enzyme studies
was not performed in all patients, which may also have led to
an underestimation of cardiovascular events.
Conclusions
In patients who were undergoing intermediate-risk noncar-
diac surgeries, the evaluation of CACS and coronary artery
stenosis with CTCA showed additive predictive value to
evaluations with RCRI alone. The CTCA should be con-
sidered in patients with poor or unknown functional capac-
ities, high RCRI score (3), and contraindications to
noninvasive stress tests. Even if patients are deemed to have
a low RCRI score, CTCA might be useful. A large sample
size and prospective study is needed to further define the
role of CTCA in pre-operative risk stratification for
intermediate-risk noncardiac surgeries.
Cs)
Relative IDI Category-Free NRI
Values p Value Event Nonevent Total p Value
up
0.39* 0.098* 58%* 22%* 0.798* 0.001*§
1.67* 0.001*§ 22%* 76%* 0.981* 0.001*§
0.833† 0.010†§ 56%† 37%† 0.185† 0.450†
1.781*§ 0.001*§ 44%* 55%* 0.991* 0.001*§
0.911† 0.001†§ 33%† 10%† 0.435† 0.076†
0.042‡ 0.588‡ 56%‡ 24%‡ 0.796‡ 0.001‡§
lus CACS 113. ‡Comparison with the ROC curves of RCRI plus multivessel disease. §Significantrs
alue
erence
en AU
nce gro
32*§
48*§
19†
17*§
52†
86‡
RCRI pntegrated discrimination improvement; NRI  net reclassification improvement; RCRI  revised
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1
1
1
1
1
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